Kitagawa Shuji
Niigata University of Pharmacy and Applied Life Sciences, Niigata, Japan.
Biol Pharm Bull. 2006 Jan;29(1):1-6. doi: 10.1248/bpb.29.1.
Overexpression of P-glycoprotein (P-gp), a plasma membrane transporter which extrudes chemotherapeutic agents out of cells, has been associated with the multidrug resistance (MDR) of cancer cells. It has been revealed that flavonoids and other polyphenols inhibit P-gp activity. Due to their inhibitory activities of polyphenols on P-gp function and their physiological safety, they are possible candidates for modulators of MDR. To determine suitable candidates, it is important to clarify the structure-activity relationships of their inhibitory activities on P-gp function. Determining the structure-activity relationships is also meaningful because the intake of dietary polyphenols may also alter drug pharmacokinetics and pharmacodynamics via inhibition of P-gp-mediated drug efflux in tissues such as the intestinal epithelium, blood-brain barrier, hepatocytes and renal tubular cells. This is a review of our recent investigations using multidrug-resistant P-gp overexpressing KB-C2 cells.
P-糖蛋白(P-gp)是一种将化疗药物排出细胞的质膜转运蛋白,其过表达与癌细胞的多药耐药性(MDR)相关。研究表明,黄酮类化合物和其他多酚类物质可抑制P-gp活性。由于多酚类物质对P-gp功能具有抑制活性且具有生理安全性,它们有可能成为MDR调节剂的候选物。为了确定合适的候选物,阐明其对P-gp功能抑制活性的构效关系很重要。确定构效关系也很有意义,因为膳食多酚的摄入还可能通过抑制肠道上皮、血脑屏障、肝细胞和肾小管细胞等组织中P-gp介导的药物外排来改变药物的药代动力学和药效学。这是一篇关于我们最近使用多药耐药性P-gp过表达的KB-C2细胞进行研究的综述。